Cas:4314-22-1 1H-1,2,3-Triazol-1-ylacetic acid manufacturer & supplier

Chemical Name:1H-1,2,3-Triazol-1-ylacetic acid

CAS.NO:4314-22-1

Synonyms:1H-1,2,3-Triazol-1-ylacetic acid;1H-1,2,3-Triazole-1-acetic acid;2-(triazol-1-yl)acetic acid;2-(1H-1,2,3-Triazol-1-yl)acetic acid

Molecular Formula:C₄H₅N₃O₂

Molecular Weight:127.101

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:344.0±44.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.648

PSA:68.01000

Exact Mass:127.038177

LogP:-0.75

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-1,2,3-Triazol-1-ylacetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(1H-1,2,3-Triazol-1-yl)acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-1,2,3-Triazole-1-acetic acid Use and application,2-(1H-1,2,3-Triazol-1-yl)acetic acid technical grade,usp/ep/jp grade.

Related News: Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage. 1H-1,2,3-Triazol-1-ylacetic acid manufacturer The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. 1H-1,2,3-Triazol-1-ylacetic acid supplier Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage. 1H-1,2,3-Triazol-1-ylacetic acid vendor Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.��s governing body. 1H-1,2,3-Triazol-1-ylacetic acid factory In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.